Literature DB >> 9451671

Cholelithiasis and pancreatic cancer. A case-control study.

A Schattner1, G Fenakel, S D Malnick.   

Abstract

To study the possible association between pancreatic cancer and cholelithiasis, we conducted a retrospective case-control study. Abdominal ultrasound of 100 consecutive cases of pancreatic cancer and that of 140 age- and gender-matched control subjects were examined by 2 observers who did not know the diagnosis. Thirty-seven patients with pancreatic cancer had cholelithiasis (37%), as compared with 23 (16%) of the control group (p < 0.001). The increased prevalence of gallstones in patients with pancreatic carcinoma remained significant when either male or female patients were compared (p < 0.02), as well as in the various age groups studied. For example, 30 (43.5%) of 69 patients 65 years of age and older had cholelithiasis versus 21 (22%) of 95 control subjects (p < 0.005). Thus, patients with pancreatic cancer were found to have a higher prevalence of gallstone disease than expected in a matched control population (relative risk, 2.2; 95% confidence interval, 1.2-4.3). This finding does not establish a causal link; however, the possibility should be pursued, more so because gallstones have been identified previously as likely risk factors for cancer in other parts of the biliary-pancreatic tract.

Entities:  

Mesh:

Year:  1997        PMID: 9451671     DOI: 10.1097/00004836-199712000-00010

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  2 in total

1.  Gallstones, cholecystectomy, and risk of digestive system cancers.

Authors:  Leticia Nogueira; Neal D Freedman; Eric A Engels; Joan L Warren; Felipe Castro; Jill Koshiol
Journal:  Am J Epidemiol       Date:  2014-01-26       Impact factor: 4.897

2.  Reply: Gallstones, cholecystectomy, and the risk for developing pancreatic cancer.

Authors:  C Bosetti; E Negri; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.